Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Revenue (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Revenue for 6 consecutive years, with $76.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 25.51% year-over-year to $76.2 million, compared with a TTM value of $270.3 million through Dec 2025, up 20.52%, and an annual FY2025 reading of $270.3 million, up 20.52% over the prior year.
  • Revenue was $76.2 million for Q4 2025 at Viemed Healthcare, up from $71.9 million in the prior quarter.
  • Across five years, Revenue topped out at $76.2 million in Q4 2025 and bottomed at $27.4 million in Q2 2021.
  • Average Revenue over 5 years is $46.7 million, with a median of $46.4 million recorded in 2023.
  • The sharpest move saw Revenue plummeted 36.06% in 2021, then soared 38.15% in 2023.
  • Year by year, Revenue stood at $32.0 million in 2021, then grew by 17.35% to $37.5 million in 2022, then surged by 35.28% to $50.7 million in 2023, then increased by 19.62% to $60.7 million in 2024, then rose by 25.51% to $76.2 million in 2025.
  • Business Quant data shows Revenue for VMD at $76.2 million in Q4 2025, $71.9 million in Q3 2025, and $63.1 million in Q2 2025.